Novocure Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +160.7% | -8.2% | -5.9% | +28.1% | +41.1% | +119.4% | +8.3% | +4.6% | -3.8% | +8.3% | -35.2% | |
| – | +162.8% | -10.9% | -6.4% | +31.1% | +36.9% | +127.2% | +7.4% | +3.5% | -6.9% | +7.0% | -41.6% | |
| – | +107.3% | -16.4% | -21.2% | +78.9% | +26.1% | +38.8% | -15.2% | -44.8% | +108.8% | -32.0% | -36.9% | |
| – | +162.6% | -18.5% | -16.5% | +34.1% | +32.6% | +161.9% | +9.8% | +3.4% | -6.1% | +5.4% | -52.3% | |
| – | +122.3% | +52.1% | +129.4% | -3.1% | +141.1% | +14.1% | +10.1% | +1.5% | -31.3% | +32.4% | +13.0% | |
| – | +294.5% | +87.9% | -13.8% | +2.4% | +5.1% | +15.7% | -10.9% | +20.3% | +29.9% | -8.0% | +17.2% | |
| – | +118.8% | +48.0% | -3.0% | -14.9% | +125.2% | -67.1% | +372.9% | -39.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +182.6% | +147.3% | +8.6% | +50.0% | +15.0% | +119.9% | +26.7% | +2.9% | +4.4% | +12.4% | -47.3% | |
| – | +62.0% | +28.8% | +36.1% | +28.6% | +33.7% | +31.6% | +25.5% | +11.3% | +12.8% | +322.3% | -70.5% | |
| – | +7,174.5% | +312.9% | +1.1% | – | – | -82.8% | +979.8% | +5.1% | +15.1% | +568.1% | -97.9% | |
| – | +38.6% | +32.0% | -6.3% | +55.2% | +38.3% | +45.3% | +35.3% | +17.4% | +10.8% | +11.3% | +16.3% | |
| – | +7,174.5% | +312.1% | +1.8% | +52.4% | +0.1% | +187.7% | +30.8% | +0.6% | +0.6% | -82.9% | +100.5% | |
| – | +156.3% | -43.2% | -20.2% | -1.1% | +94.0% | +118.8% | -13.9% | +7.5% | -17.8% | -0.6% | -5.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +15.8% | +2.4% | +3.5% | +3.7% | +5.9% | +12.0% | -5.0% | +1.2% | +1.7% | +1.4% | +3.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.